Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent

Ayub,Shiekh Gazalla; Rasool,Shabhat; Ayub,Taha; Khan,Saquib Naveed; Wani,Khursheed Alam; Andrabi,Khurshid Iqbal

doi:10.3892/mmr.2013.1862

Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent

Authors:
- Shiekh Gazalla Ayub
- Shabhat Rasool
- Taha Ayub
- Saquib Naveed Khan
- Khursheed Alam Wani
- Khurshid Iqbal Andrabi
View Affiliations

Affiliations: Department of Biotechnology, University of Kashmir, Kashmir 190006, India, Government Medical College, Srinagar 190010, India, Department of Accident and Emergency, Sheri‑Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir 190011, India, Department of Surgery, Sheri‑Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir 190011, India
Published online on: December 13, 2013 https://doi.org/10.3892/mmr.2013.1862
Pages: 749-753

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer demonstrates geographical and ethnic variation in its incidence reflecting the effect of local environmental conditions and lifestyle. The genesis of the disease has further been complexed by the involvement of a number of genes with small effects and above all by population heterogeneity. Accordingly, variations in genes, including breast cancer 1, early onset (BRCA1)/breast cancer 2, early onset (BRCA2), that have been markedly associated with the breast cancer phenotype exhibit a scattered mutational pattern in different populations. The present study was aimed to analyze the sequence variations in BRCA2 gene in a case control manner in ethnically pure Kashmiri population using PCR. Sequencing of BRCA2 exons revealed the presence of five sequence variations, four of which present in exon 11 alone were somatic and one was germline located in the U-terminal region (UTR) of exon 2. Out of these, the two somatic mutations comprised of substitutions, one representing a missense mutation leading to an amino-acid substitution at codon 991 and the other was a silent mutation at codon 1131, whereas the other two mutations located in exon 11 represented a loss of polymorphism. Codons for amino acid position 846 and 868 were demonstrated to be heterozygous polymorphic variants in 66% of the normal breast tissue samples, whereas the heterozygous polymorphic variant codons at the two loci were replaced by a homozygous genotype in associated tumor tissue in 88% of cases. These two mutations were always linked. Germline variation observed in exon 2 was located in the UTR region at contig position 13870572 (rs1799943). Other screened exons of BRCA2 did not demonstrate any sequence variation. These variations may contribute to breast cancer susceptibility along with variations in other low penetrating genes in sporadic types of breast cancer in this cohort of the population.

View Figures

View References

1	Parkin DM: International variation. Oncogene. 23:6329–6340. 2004. View Article : Google Scholar
2	Parkin DM, Whelan SL, Ferlay J, Raymond L and Young J: Cancer Incidence in Five Continents. 8. IARC Press; Lyon: 1997
3	McPherson K, Steel CM and Dixon JM: ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 321:624–628. 2000. View Article : Google Scholar : PubMed/NCBI
4	Indian Council of Medical Research. National Cancer Registry programme: Consolidated report of the population based cancer registries 1990–1996. Indian Council of Medical Research; New Delhi: 2001
5	Mittra I, Badwe RA, Desai PB, Yeole BB and Jussawalla DJ: Early detection of breast cancer in developing countries. Lancet. 1:719–720. 1989. View Article : Google Scholar : PubMed/NCBI
6	Rao DN and Ganesh B: Estimate of cancer incidence in India in 1991. Indian J Cancer. 35:10–18. 1998.PubMed/NCBI
7	Magnusson C, Baron J, Persson I, Wolk A, Bergström R, Trichopoulos D and Adami HO: Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer. 76:29–34. 1998. View Article : Google Scholar : PubMed/NCBI
8	Hamajima N, Hirose K, Tajima K, et al: Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 87:1234–1245. 2002. View Article : Google Scholar
9	Gervais-Fagnou DD, Girouard C, Laperriere N, Pintillie M and Goss PE: Breast cancer in women following supradiaphragmatic irradiations for Hodgkin’s disease. Oncology. 57:224–231. 1999.
10	Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
11	Bray F, McCarron P and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 6:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
12	Datta K and Biswas J: Influence of dietary habits, physical activity and affluence factors on breast cancer in East India: a case-control study. Asian Pac J Cancer Prev. 10:219–222. 2009.PubMed/NCBI
13	McMichael AJ and Giles GG: Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res. 48:751–756. 1988.PubMed/NCBI
14	Schulz M, Hoffmann K, Weikert C, Nöthlings U, Schulze MB and Boeing H: Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 100:942–946. 2008. View Article : Google Scholar
15	Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 360:187–195. 2002. View Article : Google Scholar
16	Lord SJ, Bernstein L, Johnson KA, et al: Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev. 17:1723–1730. 2008. View Article : Google Scholar : PubMed/NCBI
17	Winer EP, Morrow M, Osborne CK and Harris JR: Cancer of the breast. Section 2, Malignant Tumors of the Breast. Cancer: Principles & Practice of Oncology. DeVita VT: 2. 6th edition. J.B. Lippincott; Philadelphia: pp. 1651–1659. 2000
18	Huo D, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa F, Ahsan H and Olopade OI: Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer. 98:992–996. 2008. View Article : Google Scholar : PubMed/NCBI
19	Zeng Y, Xu MS, Tan SQ and Yin L: Analysis of the risk factors of breast cancer. Nan Fang Y Yi Ke Da Xue Xue Bao. 30:622–623. 2010.(In Chinese).
20	Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362:419–427. 2003. View Article : Google Scholar : PubMed/NCBI
21	Moynahan ME, Pierce AJ and Jasin M: BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell. 7:263–272. 2001. View Article : Google Scholar : PubMed/NCBI
22	Davies AA, Masson JY, McIIwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR and West SC: Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell. 7:273–282. 2001. View Article : Google Scholar : PubMed/NCBI
23	Pellegrini L, Yu DS, Lo T, Anand S, Lee M, Blundell TL and Venkitaraman AR: Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature. 420:287–293. 2002. View Article : Google Scholar : PubMed/NCBI
24	Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, Stratton MR and Easton D: Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet. 15:103–105. 1997. View Article : Google Scholar : PubMed/NCBI
25	Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM and Eyfjörd JE: A single BRCA2 mutation in male and female breast-cancer families from Iceland with varied cancer phenotypes. Nat Genet. 13:117–119. 1996. View Article : Google Scholar : PubMed/NCBI
26	Oddoux C, Struewing JP, Clayton CM, et al: The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 14:188–190. 1996.
27	Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H and Eyfjord JE: Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet. 60:1079–1084. 1997.PubMed/NCBI
28	Phillips KA: Current perspectives on BRCA1- and BRCA2-associated breast cancers. Inter Med J. 31:349–356. 2001. View Article : Google Scholar : PubMed/NCBI
29	Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton MR: Prevalence of BRCA1 and BRCA2 mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 91:943–949. 1999. View Article : Google Scholar : PubMed/NCBI
30	Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF and Venter DJ: Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol Biomarkers Prev. 8:741–747. 1999.PubMed/NCBI
31	Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H and Eyfjörd JE: Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet. 352:1337–1339. 1998. View Article : Google Scholar : PubMed/NCBI
32	Keen JC and Davidson NE: The biology of breast carcinoma. Cancer. 97:825–833. 2003. View Article : Google Scholar : PubMed/NCBI
33	Bignell G, Micklem G, Stratton MR, Ashworth A and Wooster R: The BRC repeats are conserved in mammalian BRCA2 proteins. Hum Mol Genet. 6:53–58. 1997. View Article : Google Scholar : PubMed/NCBI
34	Benson FE, Stasiak A and West SC: Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J. 13:5764–5771. 1994.PubMed/NCBI
35	Donovan JW, Milne GT and Weaver DT: Homotypic and heterotypic protein associations control Rad51 function in double-strand break repair. Genes Dev. 8:2552–2562. 1994. View Article : Google Scholar : PubMed/NCBI
36	Hays SL, Firmenich AA and Berg P: Complex formation in yeast double-strand break repair: participation of Rad51, Rad52, Rad55, and Rad57 proteins. Proc Natl Acad Sci USA. 92:6925–6929. 1995. View Article : Google Scholar : PubMed/NCBI
37	Loizidou MA, Michael T, Neuhausen SL, Newbold RF, Marcou Y, Kakouri E, Daniel M, Papadopoulos P, Malas S, Hadjisavvas A and Kyriacou K: DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus. Breast Cancer Res Treat. 115:623–627. 2009. View Article : Google Scholar : PubMed/NCBI
38	Debniak T, Scott RJ, Górski B, et al: Common variants of DNA repair genes and malignant melanoma. Eur J Cancer. 44:110–114. 2008. View Article : Google Scholar : PubMed/NCBI
39	Fackenthal JD, Sveen L, Gao Q, et al: Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet. 42:276–281. 2005. View Article : Google Scholar : PubMed/NCBI
40	Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, Altshuler D, Henderson BE and Haiman CA: Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet. 13:2431–2441. 2004. View Article : Google Scholar : PubMed/NCBI
41	Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar DE and Bhatanager D: BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat. 20:473–474. 2002. View Article : Google Scholar : PubMed/NCBI
42	Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SSV and Das BC: Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res and Treat. 88:177–186. 2004. View Article : Google Scholar : PubMed/NCBI
43	Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J, McGuire C and Neuhausen S: Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev. 14:1666–1671. 2005. View Article : Google Scholar : PubMed/NCBI